Hong Hui, Tozer Daniel J, Chen Yutong, Brown Robin B, Low Audrey, Markus Hugh S
Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
Department of Radiology, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou 310009, China.
Brain. 2025 May 13;148(5):1540-1550. doi: 10.1093/brain/awae357.
Enlarged perivascular spaces are a feature of cerebral small vessel disease, and it has been hypothesized that they might reflect impaired glymphatic drainage. The mechanisms underlying enlargement of perivascular spaces are not fully understood, but both increased inflammation and blood-brain barrier (BBB) permeability have been hypothesized to play a role. We investigated the relationship between perivascular spaces and both CNS and peripheral inflammation, in addition to BBB permeability, in cerebral small vessel disease. Fifty-four symptomatic sporadic cerebral small vessel disease patients were studied. Perivascular spaces were quantified both using a visual rating scale and by measurement of the volume of perivascular spaces in the white matter and the basal ganglia. PET-MRI was used to measure microglial activation using the radioligand 11C-PK11195, and simultaneously, BBB permeability was acquired using dynamic contrast-enhanced MRI. We determined 11C-PK11195 binding and BBB permeability in the local vicinity of individual perivascular spaces in concentric shells surrounding the perivascular spaces. In addition, both mean 11C-PK11195 binding and BBB permeability in both the white matter and the basal ganglia were determined. To assess systemic inflammation, a panel of 93 blood biomarkers relating to cardiovascular disease, inflammation and endothelial activation were measured. Within the white matter, tissue in closest proximity to perivascular spaces displayed greater 11C-PK11195 binding (P < 0.001) in the vicinity of perivascular spaces. Higher white matter perivascular spaces burden on the visual rating scale was associated with higher white matter 11C-PK11195 binding (ρ = 0.469, false discovery rate-corrected P = 0.009); values for the volume of perivascular spaces showed a similar trend. In contrast, there were no associations between the burden of basal ganglia perivascular spaces and 11C-PK11195 binding. No marker of perivascular spaces was correlated with blood-brain barrier permeability. There was no association between markers of perivascular spaces and blood biomarkers of systemic inflammation. Our findings demonstrate that white matter perivascular spaces are associated with increased 11C-PK11195 binding, consistent with neuroinflammation playing a role in enlargement of white matter perivascular spaces. Further longitudinal and intervention studies are required to determine whether the relationship between neuroinflammation and enlarged perivascular spaces is causal.
血管周围间隙扩大是脑小血管病的一个特征,据推测,它们可能反映了类淋巴系统引流受损。血管周围间隙扩大的潜在机制尚未完全明确,但炎症增加和血脑屏障(BBB)通透性增加都被认为发挥了作用。我们研究了脑小血管病中血管周围间隙与中枢神经系统和外周炎症以及血脑屏障通透性之间的关系。对54例有症状的散发性脑小血管病患者进行了研究。使用视觉评分量表以及通过测量白质和基底节中血管周围间隙的体积来对血管周围间隙进行量化。正电子发射断层扫描-磁共振成像(PET-MRI)用于使用放射性配体11C-PK11195测量小胶质细胞活化,同时,使用动态对比增强MRI获取血脑屏障通透性。我们确定了在围绕血管周围间隙的同心壳中各个血管周围间隙局部附近的11C-PK11195结合和血脑屏障通透性。此外,还确定了白质和基底节中的平均11C-PK11195结合以及血脑屏障通透性。为了评估全身炎症,测量了一组与心血管疾病、炎症和内皮细胞活化相关的93种血液生物标志物。在白质中,最接近血管周围间隙的组织在血管周围间隙附近显示出更高的11C-PK11195结合(P < 0.001)。视觉评分量表上更高的白质血管周围间隙负担与更高的白质11C-PK11195结合相关(ρ = 0.469,错误发现率校正后P = 0.009);血管周围间隙体积的值显示出类似趋势。相比之下,基底节血管周围间隙负担与11C-PK11195结合之间没有关联。没有血管周围间隙标志物与血脑屏障通透性相关。血管周围间隙标志物与全身炎症的血液生物标志物之间没有关联。我们的研究结果表明,白质血管周围间隙与11C-PK11195结合增加相关,这与神经炎症在白质血管周围间隙扩大中起作用一致。需要进一步的纵向研究和干预研究来确定神经炎症与扩大的血管周围间隙之间的关系是否具有因果性。